Clinical Trial Update: Evaluation of Resynchronization Therapy for Heart Failure [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating resynchronization therapy for heart failure (NCT00900549) has been terminated. Sponsor: Montreal Heart Institute.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Montreal Heart Institute | Conditions: Heart Failure | Phase 4 | Status: TERMINATED